the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma
Clinical trial NCT05408221 · UNKNOWN
Trial details
- NCT number
- NCT05408221
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-11
- Primary completion
- 2025-08-01
- Enrollment
- 576
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.